Nuclear texture: can it be used as a surrogate endpoint biomarker?

Area of Science:

• Biomedical Imaging
• Cell Biology
• Pathology

Background:

• Nuclear texture measurements analyze DNA distribution patterns within cell nuclei.
• These features can be reliably quantified using high-resolution image cytometry.
• Accurate measurements require stoichiometric DNA staining, with Feulgen-Thionin being a preferred method.

Purpose of the Study:

• To explore the potential of nuclear texture measurements in predicting precancerous lesion progression or regression.
• To investigate the utility of nuclear texture features as surrogate endpoint biomarkers (SEBs).
• To assess the detection of malignancy-associated changes (MACs) in normal-appearing adjacent cells.

Main Methods:

• Utilizing high-resolution image cytometry for nuclear texture feature extraction.
• Applying stoichiometric DNA stains, such as Feulgen-Thionin, for cell nucleus analysis.
• Analyzing texture features from both diagnostic cell nuclei and normal surrounding tissue, including malignancy-associated changes.

Main Results:

• Nuclear texture measurements show promise in predicting lesion progression/regression across multiple tissues (breast, cervix, lung).
• Feulgen-Thionin staining facilitates reliable DNA ploidy and texture measurements via conventional image cytometry.
• Malignancy-associated changes (MACs) in adjacent normal cells are detectable through nuclear texture analysis.

Conclusions:

• Nuclear texture analysis is a viable method for assessing precancerous lesion dynamics.
• Texture features hold potential as non-invasive surrogate endpoint biomarkers for cancer research.
• Detecting subtle changes in surrounding cells offers additional prognostic information.